Jagsonpal Pharmaceuticals Balance Sheet
- Market cap
- ₹1,522 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹163.62 – ₹306.79
As of FY25, Jagsonpal Pharmaceuticals had total assets of ₹989 crore and borrowings of ₹183 crore, against shareholders' equity of ₹805 crore — a debt-to-equity ratio of 0.35.
Jagsonpal Pharmaceuticals balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 685 |
| Borrowings | 183 |
| Other liabilities | 122 |
| Total liabilities | 989 |
| Fixed assets | 533 |
| Capital work in progress | 45 |
| Investments | 228 |
| Other assets | 228 |
| Total assets | 989 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹79.74
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Jagsonpal Pharmaceuticals balance sheet — frequently asked questions
What is the total debt of Jagsonpal Pharmaceuticals?
Jagsonpal Pharmaceuticals reported borrowings of ₹183 crore as of FY25.
What is Jagsonpal Pharmaceuticals' debt-to-equity ratio?
Based on the FY25 balance sheet, Jagsonpal Pharmaceuticals' debt-to-equity ratio is 0.35 — borrowings of ₹183 crore against equity capital and reserves of ₹805 crore.
What are Jagsonpal Pharmaceuticals' total assets?
Jagsonpal Pharmaceuticals' total assets were ₹989 crore as of FY25, including fixed assets of ₹533 crore and investments of ₹228 crore.
What is the book value per share of Jagsonpal Pharmaceuticals?
The book value per share of Jagsonpal Pharmaceuticals is ₹79.74, based on the latest reported balance sheet.
Same Data For Peers
Trade Jagsonpal Pharmaceuticals With ATS
Track JAGSNPHARM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.